Volitionrx (VNRX) Cost of Revenue (2019)

Volitionrx (VNRX) posted Cost of Revenue of $892.0 for Q3 2019.

Volitionrx (VNRX) Cost of Revenue (2019) Analysis & Trends

Volitionrx's Cost of Revenue history runs 1 years deep, the most recent figure standing at $892.0 for Q3 2019.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cost of Rev (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn	4.89 Bn
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn	2.21 Bn
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn	3.40 Bn
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn	12.00 Mn
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn	362.60 Mn
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn	441.60 Mn
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn	481.00 Mn
8	Smith & Nephew	26.99 Bn	26.41 Bn	-	-
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn	2.51 Bn
10	Volitionrx	89,525.10	-1.03 Mn	-	-

Historic Data

Download Data

Date	Value
Sep 30, 2019	892.00
Sep 30, 2019	892.00